Daniel Erlanson, San Francisco, CA (US); Raymond V. Fucini, San Bruno, CA (US); Stig Hansen, Kensington, CA (US); Jeff Iwig, Berkeley, CA (US); Shyam Krishnan, Novato, CA (US); Enrique Moya, Berkeley, CA (US); and Steven Sethofer, Emeryville, CA (US)
Assigned to Carmot Therapeutics, Inc., Berkeley, CA (US)
Filed by Carmot Therapeutics, Inc., Berkeley, CA (US)
Filed on May 13, 2022, as Appl. No. 17/744,540.
Claims priority of provisional application 63/188,342, filed on May 13, 2021.
Prior Publication US 2023/0151074 A1, May 18, 2023